BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Pharma Journalist
X-ORIGINAL-URL:http://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20230101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240709
DTEND;VALUE=DATE:20240712
DTSTAMP:20260515T172704
CREATED:20240319T002431Z
LAST-MODIFIED:20240319T003018Z
UID:38869-1720483200-1720742399@www.pharmajournalist.com
SUMMARY:3rd In Vivo Cell Engineering & Gene Editing Summit
DESCRIPTION:Welcome to the Future of Cell & Gene Therapy \nThe 3rd In Vivo Cell Engineering & Gene Editing Summit is an annual event uniting C-level in vivo experts to facilitate safe and targeted in vivo delivery of payloads while providing clarity in regulations and appropriate models to advance the next frontier of in vivo editing from research to clinic. \nExplore the full agenda – https://ter.li/snxcxi \nAs promising pre-clinical and proof of concept results continue to emerge\, the ‘dream’ of in vivo cell engineering and gene editing is rapidly becoming a reality as numerous companies push towards the clinic. \nJoin us this July to network with and gain invaluable knowledge from our world-class speaker faculty from Capstan Therapeutics\, Editas Medicine\, NanoCell Therapeutics\, Carisma Therapeutics\, Sanofi\, and more\, offering exclusive insights into their strategies for staying ahead of the curve and shaping the future of cell and gene therapy in the years ahead. \nKey Highlights: \n\nExploring data-driven case studies to outline decision making when selecting viral versus non-viral vectors\nClarifying regulatory expectations for this novel therapeutic approach to map out the future of your pipeline\nBenchmarking appropriate preclinical models to support translation to gain valuable data needed by regulatory bodies\nOutlining the considerations when scaling up towards the clinic to equip you with the tools to tackle bottlenecks\nEmphasizing target specificity and the mitigation off-site toxicities to ensure safety is front of mind in development\n\nRegister now for the best savings – https://ter.li/ssnrpz \n#InVivoCellEngineeringandGeneEditingSummit
URL:http://www.pharmajournalist.com/event/3rd-in-vivo-cell-engineering-gene-editing-summit/
LOCATION:The Colonnade Hotel\, 120 Huntington Ave\, Boston\, MA\, 02116\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240729
DTEND;VALUE=DATE:20240801
DTSTAMP:20260515T172704
CREATED:20240314T144151Z
LAST-MODIFIED:20240314T144151Z
UID:38832-1722211200-1722470399@www.pharmajournalist.com
SUMMARY:4th mRNA-Based Therapeutics Summit
DESCRIPTION:Fast-Track Your mRNA-Based Therapeutics & Vaccines from Discovery to Commercialization by Ensuring Targeted Delivery\, Durability & Tolerable Immunogenicity Across All Disease Indications \nAs mRNA developments continue to dominate industry news\, ranging from winning the Nobel Prize to new clinical candidates\, positive Phase I readouts and approvals\, the industry is set to reunite in Boston this July for the 4th mRNA-Based Therapeutics Summit. \nHear the latest unseen data from proof-of-concept studies\, platform development\, clinical updates and regulatory insights as 65+ world-class speakers take to the stage. With expert-led sessions by the likes of the FDA\, EMA\, Moderna\, BioNTech and Sanofi\, this year’s 4-track agenda will provide unmissable scientific and strategic insights into the biggest challenges faced in discovery\, translation\, clinical development\, and CMC. \n\nDates: July 29-31\, 2024\nLocation: Westin Boston Seaport District\, Boston\, MA\nEvent Program: https://ter.li/fezohk\n\nJoin the Next Generation mRNA Delivery or Regulatory Affairs Strategy focus days\, exchange business cards in Speed Networking\, quiz your peers in the Scientific Poster Session and have your voice heard during the Roundtable Discussions to maximize your experience at this year’s summit. \nDownload the agenda here: https://ter.li/fezohk \nRegister your place here (and take advantage of group discounts of up to 20% when sending your team of three or more!): https://ter.li/6vnq38
URL:http://www.pharmajournalist.com/event/4th-mrna-based-therapeutics-summit/
LOCATION:The Westin Boston Seaport District\, 425 Summer Street\, Boston\, MA\, 02210\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240729
DTEND;VALUE=DATE:20240801
DTSTAMP:20260515T172704
CREATED:20240409T112413Z
LAST-MODIFIED:20240409T112547Z
UID:38951-1722211200-1722470399@www.pharmajournalist.com
SUMMARY:5th Gamma Delta T Cell Therapies Summit
DESCRIPTION:The 5th Gamma Delta T Cell Therapies Summit will bring together experts from big pharma\, biotech and academia to delve into the details of gamma delta biology and its various subsets to offer the audience a well-rounded overview of the landscape currently and the steps needed for it to move forward. \nFind out more here: https://ter.li/yryaj1 \n \nWith a world-class speaker faculty sharing the latest insights in the field\, this meeting continues to be the one-stop shop to accelerate your gamma delta T therapies! Hear from IN8Bio\, Adicet Bio\, Acepodia\, Takeda\, Luminary Therapeutics\, LAVA Therapeutics\, OneChain Therapeutics and many more! \nAs the ONLY industry gamma delta T cell-specific meeting running this year\, these three days will expedite the translation of your vd1/vd2 pipelines from bench to bedside\, fostering prompt progress in the field. Take this opportunity to upskill your cross-functional team across discovery\, translation\, clinical development\, CMC and manufacturing to successfully translate basic research into your clinical strategy to support your IND submission. \nFind out more here: https://ter.li/yryaj1
URL:http://www.pharmajournalist.com/event/5th-gamma-delta-t-cell-therapies-summit/
LOCATION:Hilton Boston Back Bay\, 40 Dalton St\, Boston\, MA\, 02115\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
END:VCALENDAR